Apolipoprotein J/clusterin prevents a progressive glomerulopathy of aging
about
Identification of human plasma proteins as major clients for the extracellular chaperone clusterinIdentification of putative gene based markers of renal toxicityProteomic candidate biomarkers of drug-induced nephrotoxicity in the ratMining kidney toxicogenomic data by using gene co-expression modulesLow clusterin levels in high-density lipoprotein associate with insulin resistance, obesity, and dyslipoproteinemia.Clusterin/apolipoprotein J attenuates angiotensin II-induced renal fibrosisQuality control of protein folding in extracellular space.Inhibition of intracellular clusterin attenuates cell death in nephropathic cystinosis.Cholesterol in brain disease: sometimes determinant and frequently implicated.Unfolded protein response-induced ERdj3 secretion links ER stress to extracellular proteostasis.Differential effects of growth hormone versus insulin-like growth factor-I on the mouse plasma proteome.Proteomic analyses of host and pathogen responses during bovine mastitis.Clusterin attenuates the development of renal fibrosis.Clusterin Seals the Ocular Surface Barrier in Mouse Dry Eye.Novel urinary protein biomarkers predicting the development of microalbuminuria and renal function decline in type 1 diabetesInteraction of clusterin and matrix metalloproteinase-9 and its implication for epithelial homeostasis and inflammation.Relationship of clusterin with renal inflammation and fibrosis after the recovery phase of ischemia-reperfusion injuryThe role of clusterin in retinal development and free radical damage.Regulation of clusterin/apolipoprotein J, a functional homologue to the small heat shock proteins, by oxidative stress in ageing and age-related diseases.Analysis of the hippocampal proteome in ME7 prion disease reveals a predominant astrocytic signature and highlights the brain-restricted production of clusterin in chronic neurodegeneration.Preclinical perspective of urinary biomarkers for the detection of nephrotoxicity: what we know and what we need to know.IKKalpha, IKKbeta, and NEMO/IKKgamma are each required for the NF-kappa B-mediated inflammatory response program.The CLU-files: disentanglement of a mystery.Requirement of clusterin expression for prosurvival autophagy in hypoxic kidney tubular epithelial cells.Clusterin as a therapeutic target.Apolipoprotein-J prevention of fetal cardiac myoblast apoptosis induced by ethanol.Loss of clusterin expression worsens renal ischemia-reperfusion injury.Protective effect of clusterin on rod photoreceptor in rat model of retinitis pigmentosaStructural characterization of clusterin-chaperone client protein complexes.Clusterin facilitates in vivo clearance of extracellular misfolded proteins.Urine clusterin/apolipoprotein J is linked to tubular damage and renal outcomes in patients with type 2 diabetes mellitus.
P2860
Q24336992-1902A836-F117-495D-85F6-AE5308F5D1B5Q24811608-85404512-FE4C-4364-86D3-4FF27BB9EF43Q27305109-8168FAC3-7679-4DE7-B0B0-94AF69974ECEQ28822270-B5CA3289-BC90-4A6F-961F-0E88B9BB87B3Q30497410-440ED838-CFA2-4195-8363-CE6BC5F798DCQ34078756-6A62EEAE-4A6B-4F69-A1B3-827D6F11E358Q34360699-2FB634CD-70F0-4EE7-9B12-FA892406F53CQ34431244-B472D6CF-6F20-4DDC-94AC-51218E29CE71Q34621446-664569F8-E679-4FE5-B5ED-B490E5008C82Q34923990-4E0E56A4-04A8-487F-ACB5-B38FFFC9F057Q35223038-50CD267C-484F-4A40-BD9B-87454998491CQ35529379-E895598D-A82A-48CB-A0D1-EB4C5109DCA5Q35720816-FC716761-B0EC-4F5A-9683-0E27022341A5Q35786703-3B6D6985-C3C1-48C1-B485-9EA63087E21EQ35878999-2192B1FD-B6E9-498A-9AA5-5AED213B72D6Q35951860-8A0540A0-4C9A-4351-9F72-DB8925B5C06DQ36138680-B26147FE-91F5-4C61-8314-0AC530CF745FQ36172074-D10EA458-9740-4982-8950-AAA8272F9C82Q36647438-6E59B4DD-678D-4D6C-A16B-3D96ACE9E42AQ37583628-9F7B2075-8565-43EF-B52F-34BBFC9149E6Q37959015-7B117C61-8F6D-4899-A2CF-5F8F9A5B34DDQ38363101-3D123491-C31A-416A-9790-A597EB4E8E43Q38670777-6065BF16-1E54-46ED-B566-AE9F05FDA039Q38819963-8A5B4107-06CB-4248-BA54-3312AD8F63E5Q39039324-9BE0A33E-E695-453F-A220-B76F5EC1D346Q39292064-BCC26D7E-6468-4C80-91D5-1DA2ACED3237Q39763810-3851F968-A5A3-46D4-8A98-CD36F01FE812Q41214333-94EA4329-4574-49C0-BD87-1FAA8724FFDCQ42575332-B8EC2C39-AF87-4523-990E-91F061CF53FBQ43583442-EF4E0E19-67E3-4E93-96B5-51E85806C098Q48244006-622048FD-ADC3-40AA-9E21-9F9889C4979E
P2860
Apolipoprotein J/clusterin prevents a progressive glomerulopathy of aging
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Apolipoprotein J/clusterin prevents a progressive glomerulopathy of aging
@ast
Apolipoprotein J/clusterin prevents a progressive glomerulopathy of aging
@en
Apolipoprotein J/clusterin prevents a progressive glomerulopathy of aging
@nl
type
label
Apolipoprotein J/clusterin prevents a progressive glomerulopathy of aging
@ast
Apolipoprotein J/clusterin prevents a progressive glomerulopathy of aging
@en
Apolipoprotein J/clusterin prevents a progressive glomerulopathy of aging
@nl
prefLabel
Apolipoprotein J/clusterin prevents a progressive glomerulopathy of aging
@ast
Apolipoprotein J/clusterin prevents a progressive glomerulopathy of aging
@en
Apolipoprotein J/clusterin prevents a progressive glomerulopathy of aging
@nl
P2093
P2860
P1476
Apolipoprotein J/clusterin prevents a progressive glomerulopathy of aging
@en
P2093
Arthur Barrie
David Chmielewski
David Finkel
David P Witte
Judith A K Harmony
Mark E Rosenberg
Richard Girton
P2860
P304
P356
10.1128/MCB.22.6.1893-1902.2002
P407
P577
2002-03-01T00:00:00Z